Jiehui Cai
Overview
Explore the profile of Jiehui Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tian H, Chen L, Wu J, Zheng D, Yang Q, Ji Z, et al.
Front Public Health
. 2023 Jan;
10:1069172.
PMID: 36684976
Introduction: The aims of this research were to conduct the first holistic and deep scientometric analysis of electronic waste and health and provide with the prediction of research trends and...
12.
Cai J, Zhang X, Xie W, Li Z, Liu W, Liu A
Front Endocrinol (Lausanne)
. 2022 Dec;
13:1065530.
PMID: 36531485
Introduction: Breast cancer (BC) is the most common malignancy in the world and has a high cancer-related mortality rate. Basement membranes (BMs) guide cell polarity, differentiation, migration and survival, and...
13.
Zheng D, Chen L, Tian H, Yang Q, Wu J, Ji Z, et al.
Front Public Health
. 2022 Dec;
10:1034585.
PMID: 36504950
Introduction: Recently, emerging contaminants have been discovered in the aquatic environment that can cause a range of human diseases, including cancer. In this study, our scientometric analysis provides a comprehensive...
14.
Zhang X, Cai J, Chen L, Yang Q, Tian H, Wu J, et al.
Front Public Health
. 2022 Oct;
10:1016237.
PMID: 36311582
Over the past 2 years, the world has witnessed the devastating effects of the COVID-19 pandemic on humanity. Fortunately, stem cell therapy is widely used in clinical practice for the...
15.
Cai J, Ji Z, Wu J, Chen L, Zheng D, Chen Y, et al.
Front Genet
. 2022 Sep;
13:949314.
PMID: 36092873
Breast cancer (BC), the most common malignancy in women, has a high cancer-related mortality. Endoplasmic reticulum stress (ERS), a response to the accumulation of unfolded proteins, has emerging roles in...
16.
Li Z, Zheng J, Ji Z, Chen L, Wu J, Zou J, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:939048.
PMID: 35957836
Background And Objective: Previous studies determined the therapeutic effects of capecitabine-based chemotherapy regimens on early-stage triple-negative breast cancer (TNBC). However, the optimal strategy of capecitabine-based chemotherapy remains uncertain. We conducted...
17.
Chen L, Liu Y, Cai J, Ji Z, Zou J, Chen Y, et al.
Front Endocrinol (Lausanne)
. 2022 Jul;
13:887612.
PMID: 35800434
Recently, the androgen receptor has been found as a potential prognostic index and therapeutic target for breast cancer. To reveal the current research status and hotspots in this area, we...
18.
Zeng Z, Cai J, Li F, Weng Y, Huang Q, Yang H, et al.
RSC Adv
. 2022 May;
11(63):40040-40050.
PMID: 35494110
Two new dinuclear copper(ii) complexes, [Cu(ambt)(cnba)] (1) and [Cu(ambt)(clba)] (2) were synthesized with 2-amino-6-methoxybenzothiazole (ambt) as the main ligand. The structures of the two complexes were characterized by single-crystal XRD....
19.
Zhang T, Chen Y, Lin W, Zheng J, Liu Y, Zou J, et al.
Front Genet
. 2021 Nov;
12:710412.
PMID: 34737762
Thyroid cancer (THCA) is a common endocrine malignancy. With increasing incidence and low mortality, balancing the therapeutic approach is an inevitable issue. This study aimed to confirm the role of...
20.
Xu S, Liu Y, Zhang T, Zheng J, Lin W, Cai J, et al.
Front Oncol
. 2021 Jun;
11:689562.
PMID: 34094989
Background: The burden of breast cancer has been increasing globally. The epidemiology burden and trends need to be updated. This study aimed to update the burden and trends of breast...